Clinical Trial Update: A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis. [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 safety analysis evaluating oral prednisone as a pre-treatment for rituximab in rheumatoid arthritis, reporting safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• PREDNISONE (Prednisone)
• Rituximab (rituximab)

Snippet

Sponsor: University of South Florida | Conditions: Rheumatoid Arthritis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-10-04